Diuretics and mortality in acute renal failure

Area of Science:

• Critical Care Medicine
• Nephrology
• Epidemiology

Background:

• Previous research suggested diuretics might increase mortality in acute renal failure (ARF) patients, leading to discouraged use.
• The clinical decision regarding diuretic administration in critically ill ARF patients remains controversial.

Purpose of the Study:

• To investigate the association between diuretic administration and mortality rates in critically ill patients diagnosed with acute renal failure.

Main Methods:

• A prospective, multinational, epidemiologic study was conducted across 54 intensive care units in 23 countries.
• 1,743 critically ill patients with ARF were analyzed, with diuretic use assessed using three distinct multivariate models, including propensity score adjustments.
• Statistical models were employed to control for potential confounders and collinearity in assessing the relationship between diuretic use and outcomes.

Main Results:

• Approximately 70% of the studied critically ill ARF patients received diuretics, with furosemide being the most common agent.
• Common conditions leading to ARF included severe sepsis/septic shock, major surgery, low cardiac output, and hypovolemia.
• Analysis across three multivariate models revealed no statistically significant association between diuretic use and increased mortality risk in this cohort.

Conclusions:

• Diuretic prescription is common among critically ill patients with acute renal failure.
• The findings indicate that diuretic use in this population is not linked to a higher risk of mortality.
• There is equipoise to support the initiation of a randomized controlled trial evaluating diuretics in critically ill patients with renal dysfunction.